Evidence map›Paper›PMID 41345454›Full record

ArticleScientific reports2025

Interpretable ensemble learning for tumor-type prediction with a SHAP-based evaluation of CatBoost and voting classifiers.

Weronika Wolak, Anna Plichta, Hubert Orlicki

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weronika WolakDepartment of Computer Science, Faculty of Computer Science and Mathematics, Cracow University of Technology, Cracow, Poland.
Anna PlichtaDepartment of Computer Science, Faculty of Computer Science and Mathematics, Cracow University of Technology, Cracow, Poland.
Hubert OrlickiDepartment of Computer Science, Faculty of Computer Science and Mathematics, Cracow University of Technology, Cracow, Poland. hubert.orlicki@petra-po.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate early-stage diagnosis of tumours is crucial for improving patient prognosis. Modern machine learning techniques provide advanced and effective tools to support this process. In this study, both base classifiers and ensemble models were compared in the task of predicting tumour type from morphometric data. Particular attention was given to the CatBoost model as well as the Voting and Stacking classifiers. Model performance was evaluated comprehensively using standard diagnostic metrics and confusion matrices. To enhance interpretability, the SHAP framework was employed to assess the contribution of individual features to model predictions. The CatBoost model stood out due to its ability to provide explainable results through feature importance analysis and SHAP values, which highlighted the key role of parameters related to tumour size and border irregularity. The Voting Classifier improved stability and reduced variance, significantly lowering the number of false negative errors - a factor of particular clinical importance in oncological diagnostics. The Stacking Classifier achieved the highest overall predictive performance, minimising both false positive and false negative classifications by integrating heterogeneous base learners with a meta-classifier. The findings of this study confirm that interpretable ensemble methods represent a valuable approach to supporting the diagnostic process in neuro-oncology. The methodology applied here not only increases the reliability and transparency of artificial intelligence systems but also demonstrates potential for application in treatment monitoring and in predicting the risk of tumour recurrence.

Indexed as

Machine LearningNeoplasmsAlgorithmsBoosting Machine Learning AlgorithmsEnsemble LearningHumansPrognosisVotingEnsemble learningExplainable artificial intelligence (XAI)SHAPTumor classification

Identifiers

PMID41345454
PMCPMC12796192

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.